Dare Bioscience Book Value Per Share Growth & History (DARE)
Dare Bioscience's book value per share was $0.20 for fiscal 2025.
View full Dare Bioscience company overviewDare Bioscience annual book value per share history
| Fiscal year | Period ended | Book value per share | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $0.20 | $0.89 | — |
| 2024 | 2024-12-31 | -$0.69 | -$0.09 | — |
| 2023 | 2023-12-31 | -$0.61 | -$2.18 | — |
| 2022 | 2022-12-31 | $1.57 | -$3.97 | −71.62% |
| 2021 | 2021-12-31 | $5.54 | $5.87 | — |
| 2020 | 2020-12-31 | -$0.33 | -$0.60 | — |
| 2019 | 2019-12-31 | $0.27 | -$70.43 | −99.62% |
| 2018 | 2018-12-31 | $70.70 | -$193.19 | −73.21% |
| 2017 | 2017-12-31 | $263.89 | $357.63 | — |
| 2016 | 2016-12-31 | -$93.75 | -$2,233.49 | — |
| 2015 | 2015-12-31 | $2,139.74 | -$563.94 | −20.86% |
| 2014 | 2014-12-31 | $2,703.68 | $146,815.22 | — |
| 2013 | 2013-12-31 | -$144,111.54 | $13,574.82 | — |
| 2012 | 2012-12-31 | -$157,686.35 | — | — |
Dare Bioscience quarterly book value per share
| Fiscal quarter | Period ended | Book value per share | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | -$0.04 | $1.37 | — |
| Q1 2026 | 2026-03-31 | $0.05 | $1.13 | — |
| Q4 2025 | 2025-12-31 | $0.20 | $0.89 | — |
| Q3 2025 | 2025-09-30 | $0.21 | $0.38 | — |
| Q2 2025 | 2025-06-30 | -$1.41 | -$1.72 | — |
| Q1 2025 | 2025-03-31 | -$1.08 | $0.23 | — |
| Q4 2024 | 2024-12-31 | -$0.69 | -$0.09 | — |
| Q3 2024 | 2024-09-30 | -$0.17 | $0.11 | — |
| Q2 2024 | 2024-06-30 | $0.31 | $0.69 | — |
| Q1 2024 | 2024-03-31 | -$1.31 | -$2.01 | — |
| Q4 2023 | 2023-12-31 | -$0.61 | -$2.18 | — |
| Q3 2023 | 2023-09-30 | -$0.28 | -$4.05 | — |
| Q2 2023 | 2023-06-30 | -$0.38 | -$5.10 | — |
| Q1 2023 | 2023-03-31 | $0.69 | -$3.72 | −84.32% |
| Q4 2022 | 2022-12-31 | $1.57 | -$3.97 | −71.62% |
| Q3 2022 | 2022-09-30 | $3.77 | -$1.23 | −24.61% |
| Q2 2022 | 2022-06-30 | $4.72 | $3.10 | +191.73% |
| Q1 2022 | 2022-03-31 | $4.42 | $3.59 | +434.16% |
| Q4 2021 | 2021-12-31 | $5.54 | $5.87 | — |
| Q3 2021 | 2021-09-30 | $5.00 | $9.95 | — |
| Q2 2021 | 2021-06-30 | $1.62 | $0.31 | +23.62% |
| Q1 2021 | 2021-03-31 | $0.83 | -$14.79 | −94.71% |
| Q4 2020 | 2020-12-31 | -$0.33 | -$0.60 | — |
| Q3 2020 | 2020-09-30 | -$4.95 | -$17.98 | — |
| Q2 2020 | 2020-06-30 | $1.31 | -$35.27 | −96.42% |
| Q1 2020 | 2020-03-31 | $15.62 | -$24.11 | −60.68% |
| Q4 2019 | 2019-12-31 | $0.27 | -$70.43 | −99.62% |
| Q3 2019 | 2019-09-30 | $13.02 | -$87.70 | −87.07% |
| Q2 2019 | 2019-06-30 | $36.58 | -$91.84 | −71.52% |
| Q1 2019 | 2019-03-31 | $39.73 | -$126.54 | −76.10% |
| Q4 2018 | 2018-12-31 | $70.70 | -$193.19 | −73.21% |
| Q3 2018 | 2018-09-30 | $100.72 | -$344.50 | −77.38% |
| Q2 2018 | 2018-06-30 | $128.41 | -$39.43 | −23.49% |
| Q1 2018 | 2018-03-31 | $166.27 | -$153.94 | −48.07% |
| Q4 2017 | 2017-12-31 | $263.89 | $357.63 | — |
| Q3 2017 | 2017-09-30 | $445.22 | -$283.32 | −38.89% |
| Q2 2017 | 2017-06-30 | $167.84 | -$965.78 | −85.19% |
| Q1 2017 | 2017-03-31 | $320.21 | -$1,258.40 | −79.72% |
| Q4 2016 | 2016-12-31 | -$93.75 | -$2,233.49 | — |
| Q3 2016 | 2016-09-30 | $728.54 | -$1,845.79 | −71.70% |
| Q2 2016 | 2016-06-30 | $1,133.62 | -$1,865.46 | −62.20% |
| Q1 2016 | 2016-03-31 | $1,578.60 | -$779.86 | −33.07% |
| Q4 2015 | 2015-12-31 | $2,139.74 | -$563.94 | −20.86% |
| Q3 2015 | 2015-09-30 | $2,574.33 | -$559.30 | −17.85% |
| Q2 2015 | 2015-06-30 | $2,999.08 | -$449.58 | −13.04% |
| Q1 2015 | 2015-03-31 | $2,358.47 | $149,155.24 | — |
| Q4 2014 | 2014-12-31 | $2,703.68 | $146,815.22 | — |
| Q3 2014 | 2014-09-30 | $3,133.63 | — | — |
| Q2 2014 | 2014-06-30 | $3,448.66 | — | — |
| Q1 2014 | 2014-03-31 | -$146,796.78 | — | — |
| Q4 2013 | 2013-12-31 | -$144,111.54 | — | — |
Dare Bioscience book value per share trends
Over the last five fiscal years, Dare Bioscience's book value per share increased from -$0.33 to $0.20, a change of $0.53. The latest reported quarter, Q2 2026, shows -$0.04.
What book value per share means
Book value per share estimates the common shareholders’ accounting equity represented by each share. It can help compare a company’s balance-sheet value over time, although market value can differ substantially from book value.
How book value per share is calculated
TickerStat calculates book value per share as SEC-reported common shareholders’ equity divided by reported period-end common shares. Preferred equity is subtracted when separately reported, and basic weighted-average shares are used only when period-end shares are unavailable. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Dare Bioscience source filings ↗